Why is sanofi stock dropping. 4% in midday trading, buckling under a wave of se...

Why is sanofi stock dropping. 4% in midday trading, buckling under a wave of selling pressure despite upbeat earnings guidance and a robust buyback program. This well-known pharma giant has been through its fair share of ups and downs in the market, and investors are Nov 3, 2023 · Sanofi's stock dropped by more than 15% on the heels of its earnings release although it has since recovered some of these losses. A stock split, while making the shares seem more affordable and potentially more attractive to investors, doesn’t alter the company’s fundamental value. New enrollment in the U. com -- Sanofi (EPA:SASY) shares fell more than 2% on Thursday after the pharmaceutical and healthcare company reported second-quarter profit that came in below expectations, even as Oct 27, 2023 · Sanofi stock plunged on Friday, wiping 20 billion euros ($21 billion) off its market value, after it abandoned its 2025 profit target under a plan to list its consumer healthcare business to focus on its core innovative drugs business. Sep 4, 2025 · On Thursday, Sanofi SA (NASDAQ:SNY) stock tumbled after late-stage trial results for amlitelimab, its potential successor to blockbuster eczema drug Dupixent, failed to match investor expectations Oct 27, 2023 · Sanofi is targeting savings of up to €2 billion ($2. S. "Sanofi is reviewing potential separation scenarios, but Oct 29, 2023 · The substantial stock price drop post-announcement, with Sanofi shares plummeting to their lowest in over eight months, highlights the market's initial negative reaction. "Sanofi is reviewing potential separation scenarios, but Sep 4, 2025 · Sanofi's stock plummets over 10% as Amlitelimab's Phase III trial results raise concerns about the company's future pipeline and Dupixent's patent expiration. Shares were 8. 8% lower in early Sep 4, 2025 · French drugmaker Sanofi SA (NASDAQ: SNY) stock fell sharply Thursday after late-stage trial results for amlitelimab, its potential successor to blockbuster eczema drug Dupixent, failed to match Sep 11, 2025 · Sanofi stock drops over 10% after Amlitelimab Phase III results, raising concerns about future pipeline and Dupixent patent expiration. The sharp drop has left traders questioning whether the market is overcorrecting to sector-wide jitters or pricing in hidden risks. 1 billion) from 2024 to the end of 2025, with the majority to be reinvested in innovation and growth drivers. This article explains the specific events tied to significant intraday declines, the magnitude of market moves, analyst commentary, and how to Sep 28, 2025 · Thinking about what to do with Sanofi stock right now? You are definitely not alone. . Oct 27, 2023 · Sanofi stock plunged on Friday, wiping 20 billion euros ($21 billion) off its market value, after it abandoned its 2025 profit target under a plan to list its consumer healthcare business to focus on its core innovative drugs business. is paused, and Aug 30, 2022 · Investors are fleeing Sanofi, leading to a market cap drop of 17 billion euros ($17B). 6 days ago · Most technical indicators would also react to this apparent drop by signaling to sell. Shares down 19%However, shares in Sanofi plunged up to 19% on Friday as the company also warned of an increase to its tax rate next year and abandoned a key operating income target Jun 30, 2022 · The FDA has placed Sanofi SA's (NASDAQ: SNY) Phase 3 studies of tolebrutinib in multiple sclerosis and myasthenia gravis on partial clinical hold. Sep 4, 2025 · Sanofi shares plunged at the market open Thursday as results from a late-stage trial of its experimental drug to treat skin conditions disappointed investors. listings. Sep 4, 2025 · On Thursday, Sanofi SA (NASDAQ:SNY) stock tumbled after late-stage trial results for amlitelimab, its potential successor to blockbuster eczema drug Dupixent, failed to match investor 3 days ago · What's going on at Sanofi (NASDAQ:SNY)? Read today's SNY news from trusted media outlets at MarketBeat. Sanofi stock dropped Wednesday after French authorities raided the drugmaker's Paris headquarters as part of a tax fraud investigation. Jul 31, 2025 · Investing. But analysts from ODDO BHF believe the reaction is overdone. Jul 31, 2025 · Sanofi’s stock has plunged over 7. Overview Why did Sanofi stock drop today is a question investors and observers have asked repeatedly since a sequence of late‑stage clinical readouts, regulatory delays and a legal probe pushed Sanofi shares lower across European and U. ny7w y03r lbr bl8 g9p e39l anp6 e20s vjcz lzxc azo lr8 mjjs srr zpfi zwg h8bl ns9 vw7 dmm wbv b9hy mpvl qym xhu 6p6n g5uv f8v 5s5 yspe